Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sciele Pharma, Inc.
Atlanta, Georgia, USAsciele.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Prior to its acquisition by Shionogi in October 2008 for $1.1–$1.4 billion, Sciele was a commercial-stage specialty pharmaceutical company with a portfolio of branded prescription products focused on cardiovascular/metabolic diseases, women’s health, and pediatrics. The company had an established U.S. sales force and several marketed drugs but was not primarily a drug discovery or platform technology company.
- Therapeutic areas
- PulmonologyEndocrinologyPsychiatryCardiovascularWomen's Health
- Modalities
- Small molecules
- Industry
- Biotech
Beyond the preview
Go deeper on Sciele Pharma, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sciele Pharma, Inc..